Clinical Focus

  • Radiology

Academic Appointments

  • Clinical Assistant Professor, Radiology

Honors & Awards

  • Certificate of Distinction in Quality and Safety, Graduate Medical Education - Loyola University Medical Center (2016)
  • Cum Laude Award - Educational Exhibit, Radiologic Society of North America (2015)
  • Magis Star Award for Professionalism, Loyola University Medical Center (2014)
  • Graduation with Distinction, University of Kentucky College of Medicine (2013)
  • Summa cum Laude, University of Kentucky (2009)
  • Phi Beta Kappa, University of Kentucky (2009)

Professional Education

  • Board Certification: American Board of Radiology, Radiology (2019)
  • Fellowship: Stanford University Radiology Fellowships (2019) CA
  • Residency: Loyola University Medical Center Radiology Residency (2018) IL
  • Internship: Loyola University Internal Medicine Residency (2014) IL
  • Medical Education: University of Kentucky College of Medicine Registrar (2013) KY
  • Fellowship, Stanford University, Body Imaging (2018-2019)
  • Residency, Loyola University Medical Center, Diagnostic Radiology (2018)
  • Internship, Loyola University Medical Center, Internal Medicine (2014)
  • M.D., University of Kentucky College of Medicine (2013)
  • B.S., University of Kentucky College of Arts and Sciences, Biology Major, Spanish Minor, Honors Program (2009)

All Publications

  • Effects of Contrast-Enhanced Ultrasound of Indeterminate Renal Masses on Patient Clinical Management: Retrospective Analysis from Two Institutions: Retrospective Analysis From 2 Institutions. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine Eisenbrey, J. R., Kamaya, A. n., Gummadi, S. n., Bird, K. n., Burrowes, D. n., Arias, D. n., Lallas, C. D., Trabulsi, E. J., Lyshchik, A. n. 2020


    To investigate the long-term impact of contrast-enhanced ultrasound (CEUS) on the treatment of patients with indeterminate renal masses.In this retrospective study, consecutive charts of all patients receiving renal CEUS at 1 of 2 academic medical centers between January 1, 2014, and December 31, 2018, were reviewed. Patients were included in the study if they had documented chronic renal disease (estimated glomerular filtration rate < 60 mL/min/1.73 m2 ) or prior nephrectomy and received CEUS for a previously untreated renal mass.A total of 215 lesions in 157 patients were used for analysis. Contrast-enhanced ultrasound provided a final treatment recommendation in 71.6% of lesions (154 of 215). Of these 154 lesions, 7.8% (12 of 154) were lost to follow-up despite CEUS suggesting malignancy; 15.6% (24 of 154) went directly for surgical intervention, with malignancy confirmed by pathologic results in 87.5% (21 of 24) of these cases; and the remaining 76.6% (118 of 154) were deemed benign and required no additional follow-up. Of the 118 lesions diagnosed by CEUS as benign and requiring no follow-up, none showed evidence of later renal cell carcinoma development and, only 5.1% (6 of 118) of the total population was referred for further cross-sectional imaging of the mass in question. In 28.4% of all lesions (61 of 215), CEUS resulted in a recommendation for surveillance imaging at a 6- to 12-month interval, and less than 10% (6 of 61) of these underwent additional cross-sectional imaging within the recommended 6 months after CEUS.These findings highlight the impact of CEUS on clinical treatment of indeterminate renal masses, including reducing the use of the potentially nephrotoxic contrast agents and providing a direct pathway to transplant.

    View details for DOI 10.1002/jum.15383

    View details for PubMedID 32657452